Company intelligence / Profile preview

mdxhealth

Ownership: Public · MDXH
Development stage: Commercial

Overview

mdxhealth has commercialized several molecular diagnostic tests for prostate cancer and urologic diseases. Their Confirm mdx and Select mdx tests are used to improve diagnosis accuracy and inform treatment decisions. The company continues to enhance these products while developing new biomarkers for future assays. Clinical results have demonstrated high sensitivity in detecting aggressive prostate cancers using their proprietary methylation biomarker technology.

Therapeutic areas: Oncology
Modalities: Molecular diagnostics (specifically DNA methylation biomarkers and gene-based assays)
Industry: Molecular Diagnostics

Drug pipeline

4 assets

ConfirmMDx

Commercial

Indications: Prostate cancer

3 more assets in the full pipeline.

Request access →

Partnerships

Collaborations with international academic institutes such as University of Gent via the NXTGNT joint venturevarious medical centers globallyno major pharma partnerships disclosed by name

Financials

Market cap: $35.5M
Total revenue: $27.2M
Enterprise value: $122.2M

Beyond the preview

Go deeper on mdxhealth.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on mdxhealth.

Explore the full profile